Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Statement re September Factsheet

20 Oct 2015 07:00

RNS Number : 7360C
BlueCrest AllBlue Fund Ltd
20 October 2015
 



FOR IMMEDIATE RELEASE

 

20 October 2015

 

BLUECREST ALLBLUE FUND LIMITED

FACTSHEET - SEPTEMBER 2015

"A solid performance against difficult markets"

 

BlueCrest AllBlue Fund Limited (BCAB) rose by 0.3% in September, a solid performance against a backdrop of difficult markets, bringing the gain for the year to date to 2.9% (Sterling Class NAV). The rolling 12 month return remained level at 3.8% and volatility was stable, at 3.2%.

 

Markets were nervous and choppy as economic data remained generally disappointing, particularly from China. Emerging markets continued to feel the strain and the MSCI Emerging Markets index finished September down 17% on a year to date basis. Credit markets also suffered and exhibited some illiquidity, particularly in high yield. The US Federal Reserve keeping rates unchanged did nothing to settle investors' stomachs.

 

"Strongest performance came from BlueTrend 2x"

 

As in August, five of the seven underlying strategies generated positive performance. BlueCrest Multi Strategy Credit and BlueCrest Quantitative Equity detracted once again, albeit only modestly.

 

The strongest performance came from BlueTrend 2x, which rose by over 4.5% on the month. Although only three of BlueTrend's seven strategies produced positive performance, the four detracting strategies did little to dent to strong gains coming from long positioning in bonds, an orientation which was maintained by the model for the entire month. Strong performance was also seen from the short term interest rates sector. Positioning in equities and commodities was maintained net short. Overall risk levels increased slightly during the month.

 

Despite the turmoil in emerging markets, BlueCrest Emerging Markets Fund eked out a small gain. BlueCrest Multi Strategy Credit was the worst performing fund in September at -0.6% on the month. Gains were seen in volatility trading and convertible bond arbitrage with losses in long/short strategies. High yield positioning was largely flat despite illiquidity in the cash bond market seeing some sharp price falls. The risk exposure in the fund was already defensive entering September and there were further modest tactical risk reductions during the month.

 

BlueCrest Mercantile produced a small positive return as both the Trade Credit Opportunities and Bank Basel III strategies were positive. The former saw the Ukrainian sovereign CDS hedges triggered by default but the underlying trade finance positions pay out in full. The Bank Basel III strategy produced the majority of returns as emerging market mark-downs were offset by CDS hedge protection. Small losses were seen from some mining positions. A good pipeline of securitisations is being seen which are expected to become available by year end.

 

A small increase of 1.5% was made to the allocation to BlueCrest Equity Strategies for October at the expense of BlueTrend 2x and BlueCrest Capital International.

 

"The Company continued its buyback"

 

The Company continued its buyback activity during September, although selling pressure has subsequently abated. The discount remains reasonably stable, either side of 5%.

Disclaimer:

This document is directed only at: (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005; or (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and persons who receive this document who do not fall within (i) or (ii) above should not rely on or act upon this document.

 

This document is issued by BlueCrest AllBlue Fund Limited (the "Company") to and for the information of its existing shareholders and does not in any jurisdiction constitute investment advice or an invitation to invest in the shares or any other securities of the Company or any other entity (body corporate or otherwise).

 

The Company has used reasonable care to ensure that the information included in this document is accurate at the date of its issue, but does not undertake to update or revise the information, including any information relating to AllBlue Limited and its underlying funds (the "Funds") provided by BlueCrest Capital Management (UK) LLP or any member of the BlueCrest group of companies (as applicable) ("BlueCrest"), or guarantee the accuracy of such information. To the extent permitted by law neither the Company, the Funds, BlueCrest nor their directors or officers shall be liable for any loss or damage that anyone may suffer in reliance on such information.

 

The information in this document may be changed by the Company at any time. Past performance cannot be relied on as a guide to future performance. The Company's investment strategy is speculative and entails substantial risks. The value of an investment may go down as well as up and some or all of the total amount invested may be lost. This document may not, in whole or in part, directly or indirectly, be taken, transmitted or distributed into the United States of America, its territories or possessions or made available to any national, resident or citizen of the United States of America or any other jurisdiction where applicable laws prohibit its release, distribution or publication. Any failure to comply with these restrictions may be a violation of the law in relevant jurisdictions.

 

JTC (Guernsey) Limited

Secretary

 

Tel: Guernsey 01481 702400

 

END OF ANNOUNCEMENT

E&OE - in transmission

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUKAVRVAARAAA
Date   Source Headline
5th Oct 201612:49 pmRNSNet Asset Value(s)
4th Oct 20165:00 pmRNSConfirmation of Cash Exit Payment and Subscription
30th Sep 20166:30 pmRNSTotal Voting Rights
30th Sep 20166:01 pmRNSCash Received Update
27th Sep 20164:00 pmRNSExpected Receipt of Redemption Proceeds
27th Sep 201611:13 amRNSNet Asset Value(s)
26th Sep 201612:52 pmRNSNet Asset Value(s)
26th Sep 20167:00 amRNSPublication of Circular
20th Sep 20163:43 pmRNSNet Asset Value(s)
16th Sep 20166:12 pmRNSTransaction in Own Shares
13th Sep 201612:46 pmRNSNet Asset Value(s)
9th Sep 20165:30 pmRNSTransaction in Own Shares
7th Sep 201610:08 amRNSNet Asset Value(s)
5th Sep 20162:08 pmRNSNet Asset Value(s)
2nd Sep 20165:30 pmRNSTransaction in Own Shares
1st Sep 20162:20 pmRNSTotal Voting Rights
31st Aug 201610:37 amRNSNet Asset Value(s)
30th Aug 20169:31 amRNSCash Received Update
26th Aug 20166:30 pmRNSHalf Yearly Financial Report
26th Aug 20165:56 pmRNSTransaction in Own Shares
25th Aug 201610:49 amRNSNet Asset Value(s)
23rd Aug 201612:50 pmRNSNet Asset Value(s)
18th Aug 20165:33 pmRNSStatement re: Market Abuse Regulation
17th Aug 20164:03 pmRNSHolding(s) in Company
16th Aug 20164:02 pmRNSNet Asset Value(s)
9th Aug 20164:31 pmRNSConfirmation of Cash Exit Payment and Subscription
9th Aug 20161:25 pmRNSNet Asset Value(s)
4th Aug 20167:00 amRNSNet Asset Value(s)
2nd Aug 20162:39 pmRNSNet Asset Value(s)
28th Jul 201610:00 amRNSNet Asset Value(s)
21st Jul 201611:35 amRNSNet Asset Value(s)
20th Jul 20166:30 pmRNSResult of AGM
15th Jul 20165:18 pmRNSNet Asset Value(s)
14th Jul 20166:00 pmRNSNet Asset Value(s)
14th Jul 20163:49 pmRNSUpdate re Return of Capital
13th Jul 20164:29 pmRNSNotice of AGM
13th Jul 20163:56 pmRNSNet Asset Value(s)
12th Jul 201612:17 pmRNSNet Asset Value(s)
4th Jul 20166:00 pmRNSNet Asset Value(s)
1st Jul 20166:00 pmRNSRedemption Proceeds
30th Jun 201612:48 pmRNSNet Asset Value(s)
23rd Jun 20161:19 pmRNSNet Asset Value(s)
16th Jun 201612:16 pmRNSNet Asset Value(s)
10th Jun 20164:30 pmRNSNet Asset Value(s)
9th Jun 201610:30 amRNSNet Asset Value(s)
6th Jun 20163:45 pmRNSNet Asset Value(s)
3rd Jun 20167:00 amRNSAppointment of Non-Executive Director
3rd Jun 20167:00 amRNSConfirmation of Cash Exit Payment and Subscription
2nd Jun 20161:30 pmRNSNet Asset Value(s)
1st Jun 20166:00 pmRNSReceipt of Redemption Proceeds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.